Literature DB >> 2247712

Histoplasmosis: update 1989.

S F Davies1.   

Abstract

Histoplasmosis is a relatively mature disease that was first described 85 years ago. Histoplasmosis was long thought to be a rare and uniformly fatal illness. However, widespread use of skin testing in the 1940s proved that it was a common infection, especially in the central United States, and almost invariably benign. Primary histoplasmosis often presents as a self-limited, nonspecific respiratory infection, and thus, it was realized that a huge iceberg of subclinical and mildly symptomatic cases had been missed for years, since only the highly symptomatic and progressive infections had been diagnosed. Once the disease was recognized as a common one, many new clinical forms of the illness were recognized, including diffuse infiltrates due to heavy exposure, chronic cavitary disease resembling tuberculosis, and complications of primary infection, including mediastinal granuloma and the superior vena caval syndrome. Despite the mature state of histoplasmosis, it is still a disease capable of producing surprises. In this article, the history of histoplasmosis is reviewed, as well as current major concepts about the epidemiology, pathogenesis, clinical features, diagnosis, and treatment of this infection. Newer developments are then highlighted using the same outline.

Entities:  

Mesh:

Year:  1990        PMID: 2247712

Source DB:  PubMed          Journal:  Semin Respir Infect        ISSN: 0882-0546


  4 in total

1.  Pulmonary histoplasmosis as an example of imported mycoses in Japan.

Authors:  Akira Shimamoto; Motoshi Takao; Shin Shomura; Tomohito Tarukawa; Hideto Shimpo
Journal:  Gen Thorac Cardiovasc Surg       Date:  2007-08

2.  Outbreak of histoplasmosis among employees in a paper factory--Michigan, 1993.

Authors:  M G Stobierski; C J Hospedales; W N Hall; B Robinson-Dunn; D Hoch; D A Sheill
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

3.  Disseminated histoplasmosis successfully treated with liposomal amphotericin B following azathioprine therapy in a patient from a nonendemic area.

Authors:  F Poveda; J García-Alegría; M A de las Nieves; E Villar; N Montiel; A del Arco
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-05       Impact factor: 3.267

4.  Disseminated histoplasmosis in a non-immunocompromised host.

Authors:  P Harten; H H Euler; E Wolf; G Delling; H Löffler
Journal:  Clin Investig       Date:  1994-11
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.